This does not occur in CP and BP CML progenitor cells, where BCR-ABL1 further inhibits MIR300 expression levels, protecting them from apoptosis and cell cycle arrest [103]. The gene discussed is MIR300; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.